Bucillamine-induced gigantomastia with galactorrhea and hyperprolactinaemia.
Mod Rheumatol Case Rep
; 4(1): 122-125, 2020 01.
Article
em En
| MEDLINE
| ID: mdl-33086961
ABSTRACT
Gigantomastia is characterised by excessive breast growth and can occur as a rare, drug-induced adverse event. D-penicillamine is the most frequent cause of drug-induced gigantomastia. Only one case of gigantomastia due to bucillamine, an analogue of D-penicillamine, has been reported so far. We herein report a case of bucillamine-induced gigantomastia presenting with acute enlargement of the bilateral breasts and accessory breast tissue in the axillae 7 months after the start of bucillamine therapy. Awareness about this rare adverse event is important since bucillamine is still widely used in Japan and Korea.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Mama
/
Hiperprolactinemia
/
Anti-Inflamatórios não Esteroides
/
Cisteína
/
Galactorreia
/
Hipertrofia
Tipo de estudo:
Diagnostic_studies
Limite:
Female
/
Humans
País/Região como assunto:
Asia
Idioma:
En
Revista:
Mod Rheumatol Case Rep
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Japão